Thus, it was evident that the mutations in SLC5A10 and SLC2A9 had negligible effects on their expression levels, supporting functional genetic variants as the key influencing factor leading to the imbalance of SLC2A9 and SLC5A10 expression in HCC. This evidence concerns the gene SLC5A10 and hepatocellular carcinoma.